{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06276491",
            "orgStudyIdInfo": {
                "id": "XmAb541-01"
            },
            "organization": {
                "fullName": "Xencor, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase 1, Safety and Tolerability Study of XmAb\u00ae541 in Advanced Solid Tumors",
            "officialTitle": "A Phase 1, First-in-Human, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of XmAb\u00ae541 in Advanced Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "phase-safety-and-tolerability-study-of-xmab-in-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-16",
            "studyFirstSubmitQcDate": "2024-02-16",
            "studyFirstPostDateStruct": {
                "date": "2024-02-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Xencor, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose(s) for further study. The study will also evaluate effect of XmAb541 on tumor outcomes."
        },
        "conditionsModule": {
            "conditions": [
                "Ovarian Cancer",
                "Endometrial Cancer",
                "Germ Cell Tumor",
                "Testicular Germ Cell Tumor",
                "Ovarian Germ Cell Tumor"
            ],
            "keywords": [
                "Phase 1",
                "Ovarian Cancer",
                "CLDN6",
                "Testicular Cancer",
                "Germ Cell Tumor",
                "Endometrial Cancer",
                "T-cell Engager"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Dose escalation and expansion study",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 212,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose escalation and Dose Expansion of XmAb541",
                    "type": "EXPERIMENTAL",
                    "description": "Intravenous or Subcutaneous administration",
                    "interventionNames": [
                        "Biological: XmAb541"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "XmAb541",
                    "description": "Monoclonal bispecific antibody",
                    "armGroupLabels": [
                        "Dose escalation and Dose Expansion of XmAb541"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Adverse Events",
                    "timeFrame": "Day 1 to 2 years"
                },
                {
                    "measure": "Incidence of dose-limiting toxicities (DLTs)",
                    "timeFrame": "Day 1 to Day 28"
                },
                {
                    "measure": "Incidence of cytokine release syndrome (CRS)",
                    "timeFrame": "Day 1 to Day 28"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Measurement of Cmax",
                    "description": "Peak plasma concentration",
                    "timeFrame": "Day 1 to 2 years"
                },
                {
                    "measure": "Measurement of area under curve (AUC)",
                    "description": "Area under the plasma concentration versus time curve",
                    "timeFrame": "Day 1 to 1.4 years"
                },
                {
                    "measure": "Measurement of Ctrough",
                    "description": "Plasma concentration before next dose",
                    "timeFrame": "Day 1 to 2 years"
                },
                {
                    "measure": "Objective Response Rate",
                    "description": "Objective Response Rate by RECIST 1.1 assessment of CT/MRI imaging",
                    "timeFrame": "Day 1 to 2 years"
                },
                {
                    "measure": "Duration of Response",
                    "description": "Duration of Response Objective Response Rate by RECIST 1.1 assessment of CT/MRI imaging",
                    "timeFrame": "Day 1 to 2 years"
                },
                {
                    "measure": "Changes in Circulating Tumor DNA (ctDNA)",
                    "description": "Maximum variant frequency or mean/median variant frequency",
                    "timeFrame": "Day 1 to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Age \u2265 18 years. For subjects with GCTs, age \u226515 years\n* CLDN6+ tumor\n* Histological evidence of locally advanced, recurrent, or metastatic solid malignancy Ovarian, fallopian tube, or peritoneal cancer, adenocarcinoma of the endometrium (endometrial cancer, uterine cancer, or carcinoma of the uterine corpus), GCT\n* Have documented progressive disease (PD) on standard-of-care therapies appropriate for the specific tumor type; have exhausted therapies with a survival benefit or the standard therapy has no survival benefit or proven to be ineffective, intolerable, or subject is not a candidate for such available therapy.\n* Eastern Cooperative Oncology Group performance status of 0-2\n* Life expectancy \u2265 3 months\n* Adequate liver, kidney, thyroid and bone marrow function\n\nKey Exclusion Criteria:\n\n* Prior exposure to a CLDN6 targeting product\n* Ovarian cancer that is platinum refractory, or has rapid progression on most recent prior \u2265 second line systemic anticancer therapy\n* Have known active central nervous system metastases and/or carcinomatous meningitis. Patients with treated brain metastases may participate, provided they are radiologically stable.\n* Active known or suspected autoimmune disease\n* Has any condition requiring systemic treatment with corticosteroids, prednisone equivalents, or other immunosuppressive medications within 14 days prior to first dose of study drug\n* Clinically significant cardiovascular, pulmonary or gastrointestinal disease\n* Known Human immunodeficiency virus (HIV) positivity\n* Positive test for hepatitis C RNA\n* Positive test for hepatitis B surface antigen or hepatitis B core antibody (hBcAb)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "15 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Michael Chiarella",
                    "role": "CONTACT",
                    "phone": "1-858-945-2415",
                    "email": "mchiarella@xencor.com"
                }
            ],
            "locations": [
                {
                    "facility": "Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "The John Theruer Cancer Center at Hackensack University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Montefiore Einstein Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10461",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "University of Virginia",
                    "status": "RECRUITING",
                    "city": "Charlottesville",
                    "state": "Virginia",
                    "zip": "22903",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.02931,
                        "lon": -78.47668
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010051",
                    "term": "Ovarian Neoplasms"
                },
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000010049",
                    "term": "Ovarian Diseases"
                },
                {
                    "id": "D000000291",
                    "term": "Adnexal Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000006058",
                    "term": "Gonadal Disorders"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12974",
                    "name": "Ovarian Neoplasms",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16506",
                    "name": "Testicular Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M1704",
                    "name": "Carcinoma, Ovarian Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "asFound": "Germ cell tumor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12972",
                    "name": "Ovarian Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3643",
                    "name": "Adnexal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9163",
                    "name": "Gonadal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4352",
                    "name": "Ovarian Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4354",
                    "name": "Ovarian Epithelial Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T2475",
                    "name": "Germ Cells Tumors",
                    "asFound": "Germ cell tumor",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4355",
                    "name": "Ovarian Germ Cell Tumor",
                    "asFound": "Ovarian germ cell tumor",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5603",
                    "name": "Testicular Germ Cell Tumor",
                    "asFound": "Testicular germ cell tumor",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M20194",
                    "name": "Antibodies, Bispecific",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}